6,531 followers
New research: TACE Plus Lenvatinib Versus TACE Plus Sorafenib for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Prospective Cohort Study: Background and Objectives This study aimed to compare the efficacy of… https://t.co/xKppNZ